Reagents and instruments for immunology, cell biology and molecular biology.
Biotrend USA > ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.
ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.